Eyenovia, Inc.

EYEN · NASDAQ

$7.56 +3.99% (+$0.29)

Valuation

N/A

P/E N/A

EV/EBITDA N/A

P/S N/A

Growth

N/A

EPS growth N/A

Rev. growth N/A

FCF growth N/A

Profitability

N/A

Gross margin N/A

Net margin N/A

Op. margin N/A

Quality

N/A

ROIC N/A

ROE N/A

ROA N/A

Debt

N/A

Debt/Equity N/A

Current ratio N/A

Int. coverage N/A

Stability

87 /100

Stable

Beta 1.00x

Rev. volatility N/A

EPS volatility N/A

Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe

Întreabă StockBot despre EYEN

Online

Despre companie

Eyenovia, Inc. (EYEN) is a biotechnology company focused on the development and commercialization of ophthalmic drugs and technologies. The company specializes in an innovative approach to treat eye conditions such as glaucoma, myopia, and pupil dilation. Their drugs are designed to improve efficacy and reduce uncomfortable side effects associated with traditional ophthalmic medications. Eyenovia aims to provide patients and eye care professionals with better and more advanced medical solutions for eye-related issues. Investing in shares of Eyenovia, Inc. can present an attractive opportunity for investors interested in innovative medical fields with the potential to enhance the quality of life for patients with eye-related conditions.

Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.

Sector

Healthcare

Industry

Biotechnology

CEO

Michael M. Rowe

Employees

Headquarters

New York City

⌘ K

StockBot Live

Situația pieței Wall Street

Wall Street scade, randamentele se apropie de 5%

S&P 500 a scăzut -0.21%, Dow -0.44%. Randamentele de 5% au șters cștigurile anterioare din tech.

Întrebați despre asta

StockBot cunoaște 80,000+ acțiuni la nivel mondial